California asks testing labs not to inflate THC levels
California cannabis regulators have issued several warnings asking the testing laboratories authorized by the state to accurately report test results, under penalty of severe sanctions, including the potential revocation of their license.
The laboratory division of the Department of Cannabis Control (DCC) has begun inspections to confirm (or refute) the test results for cannabis flowers and other products that have already been tested, according to an email notification sent Thursday to accredited laboratories and obtained by MJBizDaily.
«Random testing of over-the-counter products will continue to give consumers confidence that the cannabis products they purchase have been tested and that the test results are accurate,» said Nicole Elliott, director of the DCC, to MJBizDaily by email on Friday.
The letter warns testing laboratories that inflating THC levels and falsifying scientific data constitutes a violation of state law.
«Reporting inaccurate results and falsifying data will result in action being taken against your license, up to and including revocation,» the notice warns.
If the results confirmed by the DCC do not match the results of the tests conducted by the laboratories, companies may be required to relabel their products, the DCC said.
«This may also result in the recall and/or embargo of cannabis or cannabis-based products,» according to the warning.
Why inflate THC levels?
The Studies show such as a product's price, THC percentage, and the recommendations of the budtender are the main factors consumers consider when choosing cannabis. However, there has been a disproportionate emphasis on THC percentage, partly due to the misconception that potency is directly linked to product quality, and partly due to a lack of understanding of the important role played by terpenes and other cannabinoids.
This focus on THC content has prompted companies in the cannabis industry (brands, growers, distributors) to game the system, particularly when economic conditions are difficult for legal operators. While consumers remain fixated on THC content, some companies are willing to deceive customers because they can charge them more.
Products from cannabis with high THC content are selling for higher prices, which has encouraged some cannabis companies and testing laboratories willing to commit fraud to manipulate the results. The industry calls this practice «lab shopping.».
Regulations generally require that the THC content listed on the label fall within a certain percentage range relative to the actual test results. In California, this threshold is 10%, which allows some labs to manipulate results or brands to get creative with their claims.
These questionable practices have led to a systemic problem of power inflation, which is detrimental to all parties involved. The lab shopping has often allowed the worst brands and laboratories to achieve better results, while highly effective brands and science-driven laboratories have suffered.
In recent years, state agencies in Arizona, Colorado, Florida, and Nevada have stepped up enforcement against noncompliant testing laboratories, imposing heavy fines and suspending licenses in some cases.
-
Cannabis in France4 weeks ago
The «cannabis» fine raised to 500 euros under the RIPOST Act
-
Cannabis in Nepal1 week ago
A Nepalese province legalizes medical cannabis
-
Cannabis in Spain4 weeks ago
The First Authorized Medical Cannabis Cultivation in the Canary Islands
-
Cannabis in France2 weeks ago
French Polynesia Is Finally Ready to Launch Its «Medical Cannabis» Pilot Program After Months of Delays
-
Business4 weeks ago
Germany Ends Public Health Insurance Coverage for Medical Cannabis Flowers
-
Cannabis in California2 weeks ago
Eight years after legalization, cannabis use in California has not increased
-
Cannabis in Africa4 weeks ago
Botswana Paves the Way for Commercial Hemp Cultivation
-
Cannabis in Pennsylvania4 weeks ago
Cannabis Legalization in Pennsylvania Once Again on Hold


You must be logged in to post a comment Login